Epigenetic Targeting of Platinum Resistant Testicular Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|16|9|789-795

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.9, 2016-10, pp. : 789-795

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Platinum Resistant Disease in Ovarian Cancer

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3009-3020

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenetic Modifiers in Cancer

By  

Current Medicinal Chemistry, Vol. 14, Iss. 24, 2007-10 ,pp. : 2540-2547

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of platinum-resistant ovarian cancer

By Trimble Edward L   Wright John   Christian Michaele C  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 8, 2001-08 ,pp. : 1299-1306

Informa Healthcare

Access to resources Recommend Favorite

Targeting epigenetic regulatory mechanisms in cancer chemoprevention

By Fay Judith R   Crowell James A   Kopelovich Levy  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 315-328

Informa Healthcare

Access to resources Recommend Favorite

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

By Naumann R. Wendel  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1397-1412

Adis International

Access to resources Recommend Favorite